Literature DB >> 20522646

Hepatic hyperplasia associated with discordant xenogeneic parenchymal-nonparenchymal interactions in human hepatocyte-repopulated mice.

Rie Utoh1, Chise Tateno, Miho Kataoka, Asato Tachibana, Norio Masumoto, Chihiro Yamasaki, Takashi Shimada, Toshiyuki Itamoto, Toshimasa Asahara, Katsutoshi Yoshizato.   

Abstract

Liver mass is optimized in relation to body mass. Rat (r) and human (h) hepatocytes were transplanted into liver-injured immunodeficient mice and allowed to proliferate for 3 or 11 weeks, respectively, when the transplants stopped proliferating. Liver/body weight ratio was normal throughout in r-hepatocyte-bearing mice (r-hep-mice), but increased continuously in h-hepatocyte-bearing mice (h-hep-mice), until reaching approximately three times the normal m-liver size, which was considered to be hyperplasia of h-hepatocytes because there were no significant differences in cell size among host (mouse [m-]) and donor (r- and h-) hepatocytes. Transforming growth factor-beta (TGF-beta) type I receptor, TGF-beta type II receptor, and activin A type IIA receptor mRNAs in proliferating r-hepatocytes of r-hep-mice were lower than in resting r-hepatocytes (normal levels) and increased to normal levels during the termination phase. Concomitantly, m-hepatic stellate cells began to express TGF-beta proteins. In stark contrast, TGF-beta type II receptor and activin A type IIA receptor mRNAs in h-hepatocytes remained low throughout and m-hepatic stellate cells did not express TGF-beta in h-hep-mice. As expected, Smad2 and 3 translocated into nuclei in r-hep-mice but not in h-hep-mice. Histological analysis showed a paucity of m-stellate cells in h-hepatocyte colonies of h-hep-mouse liver. We conclude that m-stellate cells are able to normally interact with concordant r-hepatocytes but not with discordant h-hepatocytes, which seems to be at least partly responsible for the failure of the liver size optimization in h-hep-mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20522646      PMCID: PMC2913380          DOI: 10.2353/ajpath.2010.090430

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.

Authors:  M Weinstein; S P Monga; Y Liu; S G Brodie; Y Tang; C Li; L Mishra; C X Deng
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads.

Authors:  A Kumar; V Novoselov; A J Celeste; N M Wolfman; P ten Dijke; M R Kuehn
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

Review 4.  Liver regeneration.

Authors:  Leonidas G Koniaris; Iain H McKillop; Seymour I Schwartz; Teresa A Zimmers
Journal:  J Am Coll Surg       Date:  2003-10       Impact factor: 6.113

5.  Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice.

Authors:  G A Patijn; A Lieber; D B Schowalter; R Schwall; M A Kay
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

6.  Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation.

Authors:  M Dandri; M R Burda; A Gocht; E Török; J M Pollok; C E Rogler; H Will; J Petersen
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

Review 7.  TGF-beta signaling in tumor suppression and cancer progression.

Authors:  R Derynck; R J Akhurst; A Balmain
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

8.  Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers.

Authors:  David Cassiman; Louis Libbrecht; Valeer Desmet; Carl Denef; Tania Roskams
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

9.  Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus.

Authors:  M Dandri; M R Burda; E Török; J M Pollok; A Iwanska; G Sommer; X Rogiers; C E Rogler; S Gupta; H Will; H Greten; J Petersen
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

10.  Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer.

Authors:  Jacqueline S Jeruss; Charles D Sturgis; Alfred W Rademaker; Teresa K Woodruff
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

View more
  5 in total

1.  Fibroblast Growth Factor Signaling Controls Liver Size in Mice With Humanized Livers.

Authors:  Willscott E Naugler; Branden D Tarlow; Lev M Fedorov; Matthew Taylor; Carl Pelz; Bin Li; Jennifer Darnell; Markus Grompe
Journal:  Gastroenterology       Date:  2015-05-29       Impact factor: 22.682

2.  Hepatic retinoid stores are required for normal liver regeneration.

Authors:  Igor O Shmarakov; Hongfeng Jiang; Kryscilla Jian Zhang Yang; Ira J Goldberg; William S Blaner
Journal:  J Lipid Res       Date:  2013-01-23       Impact factor: 5.922

3.  Understanding Hepatitis B Virus Dynamics and the Antiviral Effect of Interferon Alpha Treatment in Humanized Chimeric Mice.

Authors:  Vladimir Reinharz; Yuji Ishida; Masataka Tsuge; Karina Durso-Cain; Tje Lin Chung; Chise Tateno; Alan S Perelson; Susan L Uprichard; Kazuaki Chayama; Harel Dahari
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

4.  Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma?

Authors:  K Frost; K Seir; A Lackner; M Grusch; B Grasl-Kraupp; R Schulte-Hermann; C Rodgarkia-Dara
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

5.  Usage of adenovirus expressing thymidine kinase mediated hepatocellular damage for enabling mouse liver repopulation with allogenic or xenogenic hepatocytes.

Authors:  Daniel Moreno; Anangi Balasiddaiah; Oscar Lamas; Cedric Duret; Leire Neri; Laura Guembe; Miguel Galarraga; Esther Larrea; Martine Daujat-Chavanieu; Jordi Muntane; Patrick Maurel; Jose Ignacio Riezu; Jesus Prieto; Rafael Aldabe
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.